Four strategic takeaways from this year's that are important for pharma oncology leaders.
Maria Whitman
Advertisement
Articles by Maria Whitman
Advertisement
Latest Updated Articles
Beyond the Science: Commercial Implications From ASCO 2017August 21st 2017
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz
2
Pharmaceutical Executive Daily: FDA Approves Fayuvi
3
The Battle to Own the GLP-1 Patient Journey
4
Your Questions Answered: AI Drug Discovery, Portfolio Simplification, and a 30-Year First
5